{
     "PMID": "19779148",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20100105",
     "LR": "20161122",
     "IS": "1095-9203 (Electronic) 0036-8075 (Linking)",
     "VI": "326",
     "IP": "5955",
     "DP": "2009 Nov 13",
     "TI": "Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle.",
     "PG": "1005-7",
     "LID": "10.1126/science.1180962 [doi]",
     "AB": "Amyloid-beta (Abeta) accumulation in the brain extracellular space is a hallmark of Alzheimer's disease. The factors regulating this process are only partly understood. Abeta aggregation is a concentration-dependent process that is likely responsive to changes in brain interstitial fluid (ISF) levels of Abeta. Using in vivo microdialysis in mice, we found that the amount of ISF Abeta correlated with wakefulness. The amount of ISF Abeta also significantly increased during acute sleep deprivation and during orexin infusion, but decreased with infusion of a dual orexin receptor antagonist. Chronic sleep restriction significantly increased, and a dual orexin receptor antagonist decreased, Abeta plaque formation in amyloid precursor protein transgenic mice. Thus, the sleep-wake cycle and orexin may play a role in the pathogenesis of Alzheimer's disease.",
     "FAU": [
          "Kang, Jae-Eun",
          "Lim, Miranda M",
          "Bateman, Randall J",
          "Lee, James J",
          "Smyth, Liam P",
          "Cirrito, John R",
          "Fujiki, Nobuhiro",
          "Nishino, Seiji",
          "Holtzman, David M"
     ],
     "AU": [
          "Kang JE",
          "Lim MM",
          "Bateman RJ",
          "Lee JJ",
          "Smyth LP",
          "Cirrito JR",
          "Fujiki N",
          "Nishino S",
          "Holtzman DM"
     ],
     "AD": "Department of Neurology, Washington University, St. Louis, MO 63110, USA.",
     "LA": [
          "eng"
     ],
     "GR": [
          "P30 NS057105-04/NS/NINDS NIH HHS/United States",
          "P30 NS057105/NS/NINDS NIH HHS/United States",
          "K01 AG029524/AG/NIA NIH HHS/United States",
          "K01 AG029524-03/AG/NIA NIH HHS/United States",
          "R01 NS065667/NS/NINDS NIH HHS/United States",
          "AG025824/AG/NIA NIH HHS/United States",
          "MH072525/MH/NIMH NIH HHS/United States",
          "P50 AG005681/AG/NIA NIH HHS/United States",
          "P30 DK056341/DK/NIDDK NIH HHS/United States",
          "R01 MH072525/MH/NIMH NIH HHS/United States",
          "R01 AG025824/AG/NIA NIH HHS/United States",
          "K23 AG030946/AG/NIA NIH HHS/United States",
          "AG030946/AG/NIA NIH HHS/United States",
          "AG029524/AG/NIA NIH HHS/United States",
          "K23 AG030946-03/AG/NIA NIH HHS/United States",
          "NS065667/NS/NINDS NIH HHS/United States",
          "R01 MH072525-04/MH/NIMH NIH HHS/United States",
          "R01 NS065667-02/NS/NINDS NIH HHS/United States",
          "P30 DK056341-09/DK/NIDDK NIH HHS/United States",
          "R01 AG025824-03/AG/NIA NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, N.I.H., Extramural",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20090924",
     "PL": "United States",
     "TA": "Science",
     "JT": "Science (New York, N.Y.)",
     "JID": "0404511",
     "RN": [
          "0 (Acetamides)",
          "0 (Amyloid beta-Peptides)",
          "0 (Antigens, Surface)",
          "0 (Cd200r1 protein, mouse)",
          "0 (Intracellular Signaling Peptides and Proteins)",
          "0 (Isoquinolines)",
          "0 (Neuropeptides)",
          "0 (Orexin Receptors)",
          "0 (Orexins)",
          "0 (Receptors, Cell Surface)",
          "0 (Receptors, G-Protein-Coupled)",
          "0 (Receptors, Neuropeptide)",
          "9KCW39P2EI (almorexant)"
     ],
     "SB": "IM",
     "MH": [
          "Acetamides/pharmacology",
          "Alzheimer Disease/metabolism/*physiopathology",
          "Amyloid beta-Peptides/cerebrospinal fluid/*metabolism",
          "Animals",
          "Antigens, Surface/metabolism",
          "Circadian Rhythm",
          "Disease Models, Animal",
          "Extracellular Fluid/*metabolism",
          "Female",
          "Hippocampus/*metabolism",
          "Humans",
          "Intracellular Signaling Peptides and Proteins/administration & dosage/*metabolism",
          "Isoquinolines/pharmacology",
          "Light",
          "Male",
          "Mice",
          "Mice, Inbred C57BL",
          "Mice, Transgenic",
          "Neuropeptides/administration & dosage/*metabolism",
          "Orexin Receptors",
          "Orexins",
          "Receptors, Cell Surface/metabolism",
          "Receptors, G-Protein-Coupled/metabolism",
          "Receptors, Neuropeptide/metabolism",
          "Signal Transduction",
          "*Sleep",
          "Sleep Deprivation",
          "*Wakefulness"
     ],
     "PMC": "PMC2789838",
     "MID": [
          "NIHMS159243"
     ],
     "EDAT": "2009/09/26 06:00",
     "MHDA": "2010/01/06 06:00",
     "CRDT": [
          "2009/09/26 06:00"
     ],
     "PHST": [
          "2009/09/26 06:00 [entrez]",
          "2009/09/26 06:00 [pubmed]",
          "2010/01/06 06:00 [medline]"
     ],
     "AID": [
          "1180962 [pii]",
          "10.1126/science.1180962 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Science. 2009 Nov 13;326(5955):1005-7. doi: 10.1126/science.1180962. Epub 2009 Sep 24.",
     "term": "hippocampus"
}